⚕️ The information below is for educational purposes only. It is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
If you are using semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro), you have probably weighed yourself dozens of times since starting. The number going down feels like progress. But the weighing scale tells you only total mass — it cannot tell you whether the weight you lost was fat, muscle, water, or bone. For GLP-1 users, where muscle loss is a real and significant risk, this distinction matters enormously.
Body composition testing fills this gap. It tells you exactly how much of your body is fat, how much is muscle, and how healthy your bones are. This guide explains the tests available in India, their costs, and how to read your results.
Consult your healthcare provider before starting any medication.
Two people can both weigh exactly 70 kg and have completely different health profiles. One might be 25% body fat with 55 kg of lean mass. The other might be 40% body fat with 45 kg of lean mass. The second person has far greater metabolic risk — more insulin resistance, more cardiovascular risk, less functional muscle — despite the identical scale reading.
GLP-1 medications cause rapid weight loss. The STEP trials (semaglutide) found that without resistance exercise and adequate protein, approximately 38–40% of weight lost was lean mass rather than fat. A person losing 10 kg without protective habits may be losing 4 kg of muscle and only 6 kg of fat.
Body composition testing lets you confirm you are losing the right kind of weight.
What it is: A low-radiation X-ray scan measuring fat mass, lean mass, and bone mineral density across the whole body with regional breakdown (arms, legs, trunk, android and gynoid fat).
Accuracy: The clinical gold standard. Error margin: ±1–2%.
What you learn:
Where to get it in India: Available at most large corporate hospital networks — Apollo Hospitals, Fortis, Max Healthcare, Manipal, Narayana Health, Medanta. Also at imaging centres such as Mediscan, SRL Diagnostics, and select Dr. Lal PathLabs locations in metro cities.
Cost: ₹2,500–5,000 depending on city and facility. Mumbai and Delhi cost more than Bangalore, Chennai, or Hyderabad on average.
How often: A baseline scan at the start of GLP-1 therapy, then every 3–6 months during active weight loss to track lean mass preservation.
Practical notes: Takes 20–30 minutes, involves minimal radiation (far less than a chest X-ray), requires lying still. Not suitable during pregnancy.
What it is: A machine you stand on (with electrode pads for your feet) while holding two electrode-equipped handles. Harmless electrical signals pass through the body; fat, muscle, and water conduct electricity differently, allowing body composition to be estimated.
Accuracy: Good for tracking trends over time. Absolute readings can vary by ±3–5% depending on hydration, time of day, and food intake. Reliable when tested consistently under the same conditions.
What you learn:
Where to get it in India:
Cost: ₹200–500 per standalone scan. Often included in dietitian consultation packages.
How often: Monthly during active GLP-1 weight loss. InBody's lower cost and widespread availability make it the practical choice for frequent monitoring.
What it is: A trained clinician uses callipers to measure skin-fold thickness at multiple body sites (abdomen, tricep, thigh, subscapular, suprailiac). Validated equations then calculate estimated body fat percentage.
Accuracy: Moderate (±3–5%), highly dependent on clinician skill and consistency.
Where: Available at nutrition clinics, sports medicine centres, and many physiotherapy practices. The most accessible option in smaller Indian cities where InBody is unavailable.
Cost: ₹200–500 for a skilled 7-site assessment.
Limitation: Does not measure visceral fat at all — a significant gap for Indian patients, who tend to carry disproportionately high visceral fat even at normal or moderate overall body fat levels.
While not a full body composition test, waist circumference at the level of the navel is a validated, free proxy for visceral fat change. Measure it yourself every 4 weeks under consistent conditions.
Healthy targets for South Asians (ICMR / IDF criteria):
These are lower than Western cutoffs because South Asians carry more visceral fat at any given waist size.
| Category | Men | Women |
|---|---|---|
| Athletic | 6–13% | 14–20% |
| Fitness | 14–17% | 21–24% |
| Healthy | 18–24% | 25–31% |
| Overweight | 25–29% | 32–37% |
| Obese | 30%+ | 38%+ |
Note for South Asians: Many Indian diabetologists and endocrinologists use lower upper limits for healthy body fat — approximately 24% for men and 30% for women — because Indians accumulate more visceral and ectopic fat at lower percentages than Western reference populations.
Track your skeletal muscle mass number over time. Even if total muscle mass drops slightly (expected with significant weight loss), the muscle-to-fat ratio should improve. A stable or increasing skeletal muscle percentage alongside decreasing fat percentage is the ideal outcome.
Warning sign: A drop in skeletal muscle mass of more than 3–4 kg over 3 months warrants a review of protein intake and exercise habits with your doctor or dietitian.
GLP-1 medications are particularly effective at reducing visceral fat. Many users see their visceral fat score drop by 3–6 points within 6 months, even before dramatic total weight changes. This is a meaningful health improvement that the scale alone does not capture.
Some GLP-1 studies have found a neutral-to-mildly-negative effect on bone density over time. Women over 45, post-menopausal women, and anyone with pre-existing low bone density should request a full DEXA that includes bone density — not just body composition.
| Situation | Recommended Test |
|---|---|
| Starting GLP-1 (baseline) | DEXA scan |
| Monthly progress tracking | InBody at gym or dietitian |
| Bone health concern (women 45+, post-menopause) | DEXA with bone density |
| Budget-constrained | InBody at gym (₹200–500) |
| Small city, no InBody available | Skinfold callipers + waist circumference |
| Competitive or athletic goals | DEXA with full segmental analysis |
Q: My InBody says I'm 32% body fat, but my BMI is "normal." Which is right? A: Both can be simultaneously true. BMI is a height-weight ratio that tells you nothing about body composition. A person can have a "normal" BMI (18.5–24.9) with high body fat — commonly called "normal-weight obesity" or "metabolically obese, normal weight (MONW)." This pattern is particularly prevalent among South Asians. InBody or DEXA gives you the more clinically actionable information.
Q: Can I just track my waist circumference instead of getting a DEXA or InBody? A: Waist circumference is a good, free, practical proxy for visceral fat change — especially for tracking improvement. It does not tell you about lean mass preservation, which is the most important reason GLP-1 users benefit from body composition testing. Use both: waist measurement monthly, InBody or DEXA every 3–6 months.
Q: My weight has not changed this month but my InBody shows less fat and more muscle. Is that possible? A: Yes — this is body recomposition and is a highly positive outcome. You are losing fat and building muscle simultaneously, and the total weight is stable. This is the ideal scenario when doing resistance training with adequate protein on GLP-1 therapy.
Q: Is DEXA radiation safe to repeat every few months? A: Yes. A DEXA scan delivers approximately 1–5 microsieverts of radiation — equivalent to a few hours of natural background radiation. A chest X-ray delivers approximately 100 microsieverts. Annual or semi-annual DEXA scanning is considered extremely safe.
Always consult your healthcare provider before starting any medication or beginning a new exercise programme on GLP-1 therapy.
